LGVN (Longeveron Corp) שולי הרווח הגולמי

Longeveron Inc. attracts top biologists through an ethical approach to combating aging via R&D grants. The gross profit margin on the base chart of the GURU.Markets service, where -17.50 expresses the latest metric level, demonstrates financial stability. Ultra-cold logistics guarantee the viability of the drugs, while binary development risks are mitigated by a focus on rare pediatric pathologies.
פילוחי מדדים מקיפים ואנליטיקה עבור Longeveron Inc. (LGVN)

Developing cellular technologies to combat aging and rare pathologies requires Longeveron Inc. (LGVN) to maintain high efficiency in managing direct costs. By analyzing the gross margin ratio, an investor assesses the portion of revenue remaining after deducting the cost of goods sold, which determines the business's ability to scale innovations without excessive capital absorption, characterizing this asset as a high-risk venture instrument.